MGC Pharmaceuticals Ltd - ESG Rating & Company Profile powered by AI
Alternative companies in the rating peer group for MGC Pharmaceuticals Ltd are shown below. This page displays a zero-cost ESG assessment covering MGC Pharmaceuticals Ltd. If you work at MGC Pharmaceuticals Ltd and you would like to licence your ESG aseessment, please contact us.
MGC Pharmaceuticals Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | MGC Pharmaceuticals Ltd | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does MGC Pharmaceuticals Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd report the average age of the workforce?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd offer flexible work?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd conduct supply chain audits?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose water use targets?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid MGC Pharmaceuticals Ltd have a product recall in the last two years?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas MGC Pharmaceuticals Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose parental leave metrics?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs MGC Pharmaceuticals Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose its waste policy?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd report according to TCFD requirements?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose energy use targets?
Sign up for free to unlockDoes MGC Pharmaceuticals Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes MGC Pharmaceuticals Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for MGC Pharmaceuticals Ltd
These potential risks are based on the size, segment and geographies of the company.
MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. The company also provides ArtemiC range of products and cannabinoid products, as well as non-pharma products. In addition, it offers consulting services, including clinical research services. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is based in West Perth, Australia.